Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-21

Clinical Trial Update: Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion. [NA]

View source ↗

Summary

A Charles University trial is evaluating the use of indocyanine green fluorescence to assess perfusion of the pancreatic remnant in patients at risk for pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Pancreatic Fistula | NA | Status: RECRUITING